The impact of preoperative percutaneous transthoracic needle biopsy on pleural recurrence in clinically early-stage non-small cell lung cancer
Open Access
- 1 October 2025
- journal article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8300-8312
Abstract
Background: The potential association between preoperative percutaneous transthoracic needle biopsy (PTNB) and pleural recurrence in lung cancer remains controversial. This study aimed to determine whether PTNB increases the risk of pleural recurrence in patients with clinically diagnosed stage I non-small cell lung cancer (NSCLC). Methods: We retrospectively analyzed 1,733 patients with clinical stage I NSCLC who underwent surgical resection between January 2018 and December 2020. Patients were divided into the PTNB group (n=699) and the non-PTNB group (n=1,034). After 1:1 propensity score matching (PSM), risk factors for pleural recurrence were assessed using Fine-Gray subdistribution hazard models. Cumulative incidence rate and overall survival (OS) were also analyzed. Results: After matching, 530 patients were included in each group. Multivariate Fine-Gray analysis revealed that PTNB [subdistribution hazard ratio (sHR) =3.74; 95% confidence interval (CI): 1.06–13.20; P=0.040] and visceral pleural invasion (VPI) (sHR =3.12; 95% CI: 1.10–8.90; P=0.03) were independent risk factors for isolated pleural recurrence, whereas lymphatic invasion was not (sHR =2.32; 95% CI: 0.82–6.56; P=0.11). For all types of recurrence, PTNB, VPI, and lymphatic invasion were significant predictors (all PConclusions: Preoperative PTNB was statistically correlated with an increased pleural recurrence in clinical stage I NSCLC, even among patients without conventional high-risk pathological features. Careful consideration is warranted when deciding on PTNB for early-stage disease.Keywords
This publication has 23 references indexed in Scilit:
- Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I lung cancer patients who underwent curative resectionLung Cancer, 2017
- Management of malignant pleural effusion: challenges and solutionsCancer Management and Research, 2017
- Diagnosis and management options in malignant pleural effusionsLung India, 2017
- Preoperative Percutaneous Transthoracic Needle Biopsy Increased the Risk of Pleural Recurrence in Pathological Stage I Lung Cancer Patients With Sub-pleural Pure Solid NodulesCancer Investigation, 2016
- Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resectionEuropean Journal of Cardio-Thoracic Surgery, 2014
- Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional SurgeryChest, 2013
- Establishing the Diagnosis of Lung CancerChest, 2013
- Incidence of Pleural Recurrence after Computed Tomography-Guided Needle Biopsy in Stage I Lung CancerPLOS ONE, 2012
- Risk of Pleural Recurrence After Computed Tomographic-Guided Percutaneous Needle Biopsy in Stage I Lung Cancer PatientsThe Annals of Thoracic Surgery, 2011
- Multiple primary lung cancers.1975